Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors
Status:
Not yet recruiting
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
Neurosurgery is a risk factor for delirium. Dexmedetomidine might reduce delirium by reducing
neuroinflammation, improving postoperative analgesia and sleep quality. The the primary
hypothesis is that perioperative administration of dexmedetomidine can reduce the incidence
of postoperative delirium